71 results
DEFM14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Proxy related to merger
7:44am
, including the fact that our stockholders would forego the opportunity to realize the potential long-term value of the successful execution of our current … the business, operations, prospects, strategic and short- and long-term operating plans, access to capital to fund operating plans and cost
PRER14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Preliminary revised proxy
7:19am
to implement its business strategy, including the fact that our stockholders would forego the opportunity to realize the potential long-term value … risks. Taking into account the business, operations, prospects, strategic and short- and long-term operating plans, access to capital to fund
PREM14A
CERE
Cerevel Therapeutics Holdings Inc
5 Jan 24
Preliminary proxy related to merger
5:13pm
ability to implement its business strategy, including the fact that our stockholders would forego the opportunity to realize the potential long-term value … and other business risks. Taking into account the business, operations, prospects, strategic and short- and long-term operating plans, access
DEFA14A
1us uj5yhb
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-2.1
52m fsg8l4jozd5cc
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-99.1
hgu2znc8rleagcfk
1 Nov 23
Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
6:39am
8-K
EX-1.1
01kss7hwper2iy
12 Oct 23
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
4:19pm
424B5
o9cwfo1vmg143sed
12 Oct 23
Prospectus supplement for primary offering
4:16pm
424B5
p2g3n1om
11 Oct 23
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
ronu87anujjf frmo6zk
2 Aug 23
Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
6:43am
8-K
EX-99.1
sbqn2vnr 8xeq
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am
8-K
4ulzhg5
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am